🔎 Trials Near Me

Home › Psoriasis › Massachusetts

Psoriasis clinical trials in Massachusetts

9 studies for Psoriasis are looking for participants at sites in Massachusetts.

Cities in Massachusetts

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

  • Kuchnir Dermatology & Dermatologic Surgery, Milford
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Sep 3, 2026 · NCT06979453

The CorEvitas Psoriasis (PSO) Registry

  • Waltham
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT02707341

CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry

  • CorEvitas, LLC, Waltham
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT06100991

PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study

  • CorEvitas, LLC, Waltham
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT07648602

PPD™ CorEvitas™ Psoriasis (PSO) Rapid Response Non-Interventional Study

  • CorEvitas, LLC, Waltham
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT07615712

Multi-Center PAMPA Study

  • Brigham and Women's Hospital, Boston
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Mar 30, 2026 · NCT05004727

A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis

  • Local Institution, Waltham
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 23, 2024 · NCT05744466

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.